Cargando…

Diet supporting therapy for inflammatory bowel diseases

PURPOSE: Non-specific inflammatory bowel diseases (IBD) include Crohn's disease and ulcerative colitis. More and more often attention is paid to the possibility of dietary support for inflammatory bowel diseases. METHODS: The following review article considers the role of dietary components in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikut, Justyna, Konecka, Nina, Ziętek, Maciej, Kulpa, Danuta, Szczuko, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275544/
https://www.ncbi.nlm.nih.gov/pubmed/33788019
http://dx.doi.org/10.1007/s00394-021-02489-0
_version_ 1783721737813229568
author Kikut, Justyna
Konecka, Nina
Ziętek, Maciej
Kulpa, Danuta
Szczuko, Małgorzata
author_facet Kikut, Justyna
Konecka, Nina
Ziętek, Maciej
Kulpa, Danuta
Szczuko, Małgorzata
author_sort Kikut, Justyna
collection PubMed
description PURPOSE: Non-specific inflammatory bowel diseases (IBD) include Crohn's disease and ulcerative colitis. More and more often attention is paid to the possibility of dietary support for inflammatory bowel diseases. METHODS: The following review article considers the role of dietary components in the treatment of IBD as: pteridines, probiotics, bovine immunoglobulin, vitamin D, omega-3, flavonoids, polyphenols, curcumin and phosphatidylcholine. The article also discusses plant raw materials of arjuna, soy protein and nettles, trying to summarize their effect on quenching the inflammatory process within the intestines. This review focuses on the possibilities of dietary components and supplementation use to improve the pharmacotherapy response as well as the general clinical patients’ condition. RESULTS: The mechanism of action of supportive therapy is based on reduction in oxidative stress, maintaining the adequate balance between Th1 and Th2 lymphocytes by affecting cytokines, increasing riboflavin supply for macrophages, increasing expression of vitamin D receptor, regulation by decreasing the expression of NF-κB in liver cells and ability to inhibit the COX2 entrance and inactivate prostaglandins that are involved in the inflammatory process and 12-lipoxygenase pathway inhibition. CONCLUSION: Considering clinical researches, it seems that the use of the above-mentioned ingredients in the diet of patients suffering IBD may positively influence the treatment process and maintenance of remission.
format Online
Article
Text
id pubmed-8275544
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82755442021-07-20 Diet supporting therapy for inflammatory bowel diseases Kikut, Justyna Konecka, Nina Ziętek, Maciej Kulpa, Danuta Szczuko, Małgorzata Eur J Nutr Review PURPOSE: Non-specific inflammatory bowel diseases (IBD) include Crohn's disease and ulcerative colitis. More and more often attention is paid to the possibility of dietary support for inflammatory bowel diseases. METHODS: The following review article considers the role of dietary components in the treatment of IBD as: pteridines, probiotics, bovine immunoglobulin, vitamin D, omega-3, flavonoids, polyphenols, curcumin and phosphatidylcholine. The article also discusses plant raw materials of arjuna, soy protein and nettles, trying to summarize their effect on quenching the inflammatory process within the intestines. This review focuses on the possibilities of dietary components and supplementation use to improve the pharmacotherapy response as well as the general clinical patients’ condition. RESULTS: The mechanism of action of supportive therapy is based on reduction in oxidative stress, maintaining the adequate balance between Th1 and Th2 lymphocytes by affecting cytokines, increasing riboflavin supply for macrophages, increasing expression of vitamin D receptor, regulation by decreasing the expression of NF-κB in liver cells and ability to inhibit the COX2 entrance and inactivate prostaglandins that are involved in the inflammatory process and 12-lipoxygenase pathway inhibition. CONCLUSION: Considering clinical researches, it seems that the use of the above-mentioned ingredients in the diet of patients suffering IBD may positively influence the treatment process and maintenance of remission. Springer Berlin Heidelberg 2021-03-31 2021 /pmc/articles/PMC8275544/ /pubmed/33788019 http://dx.doi.org/10.1007/s00394-021-02489-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Kikut, Justyna
Konecka, Nina
Ziętek, Maciej
Kulpa, Danuta
Szczuko, Małgorzata
Diet supporting therapy for inflammatory bowel diseases
title Diet supporting therapy for inflammatory bowel diseases
title_full Diet supporting therapy for inflammatory bowel diseases
title_fullStr Diet supporting therapy for inflammatory bowel diseases
title_full_unstemmed Diet supporting therapy for inflammatory bowel diseases
title_short Diet supporting therapy for inflammatory bowel diseases
title_sort diet supporting therapy for inflammatory bowel diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275544/
https://www.ncbi.nlm.nih.gov/pubmed/33788019
http://dx.doi.org/10.1007/s00394-021-02489-0
work_keys_str_mv AT kikutjustyna dietsupportingtherapyforinflammatoryboweldiseases
AT koneckanina dietsupportingtherapyforinflammatoryboweldiseases
AT zietekmaciej dietsupportingtherapyforinflammatoryboweldiseases
AT kulpadanuta dietsupportingtherapyforinflammatoryboweldiseases
AT szczukomałgorzata dietsupportingtherapyforinflammatoryboweldiseases